The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
The promise and peril of chemical probes
Open accessAbstract
Chemical probes are powerful reagents with increasing impacts on biomedical research. However, probes of poor quality or that are used incorrectly generate misleading results. To help address these shortcomings, we will create a community-driven wiki resource to improve quality and convey current best practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., Reddy, H., Caivano, M., & Cohen, P. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510095 · Cited by 4,366
Self-citationVlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,248
Hidaka, H., Inagaki, M., Kawamoto, S., & Sasaki, Y. (1984) · Biochemistry · doi:10.1021/bi00316a032 · Cited by 2,688
Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinase
Tamaoki, T., Nomoto, H., TAKAHASHI, I., Kato, Y., Morimoto, M., & Tomita, F. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90008-2 · Cited by 2,452
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Molina, D. M., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., & Nordlund, P. (2013) · Science · doi:10.1126/science.1233606 · Cited by 2,261
Click Chemistry for Drug Development and Diverse Chemical–Biology Applications
Prakasam, T., Matosiuk, D., & Jóźwiak, K. (2013) · Chemical Reviews · doi:10.1021/cr200409f · Cited by 1,933
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Göttlicher, M., Minucci, S., Zhu, P., Krämer, O. H., Schimpf, A., Giavara, S., Sleeman, J. P., Coco, F. L., Nervi, C., Pelicci, P. G., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,930
Targeting bromodomains: epigenetic readers of lysine acetylation
Filippakopoulos, P., & Knapp, S. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4286 · Cited by 1,298
Self-citationDorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism
Yu, P. B., Hong, C. C., Sachidanandan, C., Babitt, J. L., Deng, D. Y., Hoyng, S. A., Lin, H. Y.-F., Bloch, K. D., & Peterson, R. T. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.54 · Cited by 1,059
Cited by
Sorted by citations
Items 501–600 of 902
Mbefo, M. K., Berger, A., Schouwey, K., Gérard, X., Kostic, C., Beryozkin, A., Sharon, D., Dolfuss, H., Munier, F. L., Tran, H. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179331 · Cited by 10
Covalent‐Allosteric Inhibitors to Achieve Akt Isoform‐Selectivity
Quambusch, L., Landel, I., Depta, L., Weisner, J., Uhlenbrock, N., Müller, M. P., Glanemann, F., Althoff, K., Siveke, J. T., & Rauh, D. (2019) · Angewandte Chemie · doi:10.1002/ange.201909857 · Cited by 10
A conversation on using chemical probes to study protein function in cells and organisms
(2022) · Nature Communications · doi:10.1038/s41467-022-31271-x · Cited by 10
Hoque, M., Abbassi, R. H., Froio, D., Man, J., Johns, T. G., Stringer, B. W., Day, B. W., Pajic, M., Kassiou, M., & Munoz, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.06.023 · Cited by 11
Crowdsourced mapping extends the target space of kinase inhibitorsPreprint
Cichońska, A., Ravikumar, B., Allaway, R. J., Park, S., Wan, F., Isayev, O., Li, S., Mason, M. J., Lamb, A. E., Tanoli, Z., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.31.891812 · Cited by 10
Self-citationThe Ecstasy and Agony of Assay Interference Compounds
Aldrich, C. C., Bertozzi, C. R., Georg, G. I., Kiessling, L. L., Lindsley, C. W., Liotta, D. C., Merz, K. M., Schepartz, A., & Wang, S. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00023 · Cited by 10
Podversnik, H., Jha, S., Macheroux, P., & Breinbauer, R. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116831 · Cited by 9
Open resources for chemical probes and their implications for future drug discovery
Balıkçı, E., Marques, A.-S. M. C., Hansen, J. S., & Huber, K. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2199979 · Cited by 11
Self-citationUguen, M., Liu, T., James, L. I., & Frye, S. V. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00661 · Cited by 9
Self-citationSaha, S. J., Siddiqui, A. A., Pramanik, S., Saha, D., De, R., Mazumder, S., Debsharma, S., Nag, S., Banerjee, C., & Bandyopadhyay, U. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.8b00178 · Cited by 8
Unveiling (−)‐Englerin A as a Modulator of L‐Type Calcium Channels
Rodrigues, T., Sieglitz, F., Somovilla, V. J., Cal, P. M. S. D., Galione, A., Corzana, F., & Bernardes, G. J. L. (2016) · Angewandte Chemie · doi:10.1002/ange.201604336 · Cited by 9
Mannich Base PIP-199 Is a Chemically Unstable Pan-Assay Interference Compound
Wu, X., Sudhakar, H. K., Alcock, L. J., & Lau, Y. H. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00674 · Cited by 9
Modular Nanotransporters Delivering Biologically Active Molecules to the Surface of Mitochondria
Khramtsov, Y. V., Ulasov, A. V., Slastnikova, T. A., Rosenkranz, A. A., Lupanova, T. N., Georgiev, G. P., & Sobolev, A. S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15122687 · Cited by 8
The first international workshop on the epigenetics of osteoarthritis
Meulenbelt, I., Bhutani, N., den Hollander, W., Gay, S., Oppermann, U., Reynard, L., Skelton, A., Young, D., Beier, F., & Loughlin, J. (2017) · Connective Tissue Research · doi:10.3109/03008207.2016.1168409 · Cited by 8
Prieto-Martínez, F. D., Peña‐Castillo, A., Méndez‐Lucio, O., Gortari, E. F., & Medina‐Franco, J. L. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2016.05.001 · Cited by 8
Defining Metabolic and Nonmetabolic Regulation of Histone Acetylation by NSAID Chemotypes
Shrimp, J. H., Garlick, J. M., Tezil, T., Sorum, A. W., Worth, A. J., Blair, I. A., Verdin, E. M., Snyder, N. W., & Meier, J. L. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00943 · Cited by 9
Murawska, G. M., Vogel, C., Jan, M., Lu, X., Schild, M., Slabicki, M. M., Zou, C., Zhanybekova, S., Manojkumar, M., Petzold, G., et al. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.1c00771 · Cited by 9
Zang, J., Cambet, Y., Jaquet, V., & Bach, A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1075328 · Cited by 9
Focusing on probe-modified peptides: a quick and effective method for target identification
Sun, H., Ren, Y., Hou, W., Li, L., Zeng, F., Li, S., Ma, Y., Liu, X., Chen, S., & Zhang, Z. (2016) · Chemical Communications · doi:10.1039/c6cc04030f · Cited by 9
Rational Adaptation of L3MBTL1 Inhibitors to Create Small‐Molecule Cbx7 Antagonists
Simhadri, C., Daze, K. D., Douglas, S. F., Milosevich, N., Monjas, L., Dev, A., Brown, T. M., Hirsch, A. K. H., Wulff, J. E., & Hof, F. A. (2019) · ChemMedChem · doi:10.1002/cmdc.201900021 · Cited by 9
The chemical probe – scopes, limitations and challenges
Stark, H. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1781086 · Cited by 9
Xu, D. D., Zhou, D., Bum‐Erdene, K., Bailey, B. J., Sishtla, K. L., Liu, S., Wan, J., Aryal, U. K., Lee, J. A., Wells, C. D., et al. (2020) · ACS Chemical Biology · doi:10.1021/acschembio.0c00078 · Cited by 8
Huang, C., Harris, C. L., Siddiqui, G., & Jörg, M. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00726 · Cited by 8
Enhancing Selectivity and Potency of S N Ar Covalent Inhibitors of NADPH Oxidase Enzymes
Ogboo, B. C., Patel, K. B., Massari, M., Marchese, S., Reis, J., Joyce, E. J., Lin, M.-C. J., Rabb, J. D., Abidakun, O. A., Lin, Q., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01272 · Cited by 8
Roßmann, K., Pabst, U., Baciu, B. C., Sun, S., Huhn, C., Olesen, C. H., Kowald, M., Tapp, E., Bieck, M., Birke, R., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-68134-0 · Cited by 9
Bieberich, A. A., Laitinen, T., Maffuid, K., Fatig, R. O., Torrice, C., Morris, D. C., Crona, D. J., & Asquith, C. R. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-15552-5 · Cited by 9
Small-Molecule Probes as Pharmacological Tools for the Bone Morphogenetic Protein Signaling Pathway
Riege, D., Herschel, S., Fenkl, T., & Schade, D. (2023) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00170 · Cited by 9
Rapid, potent, and persistent covalent chemical probes to deconvolute PI3Kα signaling
Bissegger, L., Constantin, T. A., Keleş, E., Raguž, L., Barlow-Busch, I., Orbegozo, C., Schaefer, T., Borlandelli, V., Bohnacker, T., Sriramaratnam, R., et al. (2024) · Chemical Science · doi:10.1039/d4sc05459h · Cited by 9
A Small‐Molecule Drug for the Self‐Checking of Mitophagy
Gao, Y., Bai, Q., Ren, Y., Shao, X., Zhang, M., Wu, L., Lewis, S. E., James, T. D., Chen, X. S., & Chen, Q. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202421269 · Cited by 8
Potential of Enzymomics Methodologies to Characterize Disease-Related Protein Functions
Komatsu, T. (2017) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c17-00144 · Cited by 8
Bergqvist, F., Sundström, Y., Shang, M.-M., Gunnarsson, I., Lundberg, I. E., Sundström, M., Jakobsson, P., & Berg, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00613 · Cited by 8
Self-citationIndustrial Organic Synthesis in Life Sciences – Today and Tomorrow
Nising, C. F., & von Nussbaum, F. (2022) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202200252 · Cited by 8
Liu, L., Rovers, E., & Schapira, M. (2022) · Database · doi:10.1093/database/baac088 · Cited by 8
Self-citationDistinct phases of cellular signaling revealed by time-resolved protein synthesis
Lee, G., & Muir, T. W. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01677-3 · Cited by 10
Tomohara, K., Ito, T., Onikata, S., Furusawa, K., Kato, A., & Adachi, I. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.04.082 · Cited by 8
Gajanayaka, N., O’Hara, S., Konarski, Y., Fernandes, J. R., Muthumani, K., Kozlowski, M., Angel, J. B., & Kumar, A. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.4a0716-332rr · Cited by 8
Chemical Proteomics for Target Discovery of Head-to-Tail Cyclized Mini-Proteins
Hellinger, R., Thell, K., Vasileva, M., Muhammad, T., Gunasekera, S., Kümmel, D., Göransson, U., Becker, C., & Gruber, C. W. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00073 · Cited by 9
Sundström, Y., Shang, M.-M., Panda, S. K., Grönwall, C., Wermeling, F., Gunnarsson, I., Lundberg, I. E., Sundström, M., Jakobsson, P., & Berg, L. (2020) · Translational research · doi:10.1016/j.trsl.2020.09.003 · Cited by 8
Self-citationHigh-Throughput Screening (HTS) Technology
Roy, A. (2021) · Springer eBooks · doi:10.1007/978-3-030-57401-7_73 · Cited by 9
Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor
Xiong, Y., Greschik, H., Johansson, C., Seifert, L., Gamble, V., Park, K., Fagan, V., Li, F., Chau, I., Vedadi, M., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00121 · Cited by 7
Self-citationInsights of affinity-based probes for target identification in drug discovery
Wang, H., Liu, L., Zhang, Z., Li, C., Wang, K., Gao, J., Hu, Q., Wang, W., & Li, H. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117711 · Cited by 7
Advances in BRET probes for intracellular target engagement studies
Capener, J. L., Schwalm, M. P., Vasta, J. D., Michaud, A., Teske, K. A., Marsiglia, W. M., Huber, K., Dar, A. C., Knapp, S., Axtman, A. D., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-025-02103-y · Cited by 9
Self-citationZhang, Y., Zhai, Y., Liu, C., Chen, M., Zhang, Y., Bian, Z., Chang, X., Hu, Z., Li, J., Zhang, C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69127-3 · Cited by 9
Dutta, N., Gerke, J. A., Odron, S. F., Morris, J. D., Hruby, A. J., Kim, J., Torres, T. C., Shemtov, S. J., Clarke, J. G., Chang, M. C., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01144-w · Cited by 6
Kumar, G., Agarwala, P. K., Srivatsav, A. T., Ravula, A., Ashmitha, G., Balakrishnan, S., Kapoor, S., & Narayan, R. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00336 · Cited by 7
Getting a Handle on Chemical Probes of Chomatin Readers
Waybright, J. M., & James, L. I. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0274 · Cited by 7
Potjewyd, F., Annor‐Gyamfi, J. K., Aubé, J., Chu, S., Conlon, I. L., Frankowski, K. J., Guduru, S. K. R., Hardy, B. P., Hopkins, M. D., Kinoshita, C., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12253 · Cited by 8
Self-citationApplying HT-SAXS to chemical ligand screening
Brosey, C. A., Shen, R., Moiani, D., Jones, D. E., Burnett, K. H., Hura, G. L., & Tainer, J. A. (2022) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2022.09.022 · Cited by 7
Gasdermins assemble; recent developments in bacteriology and pharmacology
Greenwood, C. S., Wynosky-Dolfi, M. A., Beal, A. M., & Booty, L. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1173519 · Cited by 6
Chemical Biology Approaches for Characterization of Epigenetic Regulators
Baršytė-Lovejoy, D., Szewczyk, M., Prinos, P., Lima‐Fernandes, E., Ackloo, S. Z., & Arrowsmith, C. H. (2016) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2016.01.011 · Cited by 7
Self-citationMetal-binding effects of sirtuin inhibitor sirtinol
Akam, E. A., Gautam, R., & Tomat, E. (2015) · Supramolecular chemistry · doi:10.1080/10610278.2015.1092537 · Cited by 7
Design and Applications of Bifunctional Small Molecules in Biology
Boyd, S. R., Chang, L., de Rezende, W. C., Raji, I. O., Kandel, P., Holmes, S. L., & Young, D. W. (2020) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2020.140534 · Cited by 7
Selective Inhibition of Cysteine-Dependent Enzymes by Bioorthogonal Tethering
Spear, L. A., Huang, Y., Chen, J., Nödling, A. R., Virdee, S., & Tsai, Y. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167524 · Cited by 7
EFMC, Medicinal Chemistry and Chemical Biology in Europe
Auberson, Y. P. (2020) · ChemMedChem · doi:10.1002/cmdc.202000178 · Cited by 7
West, C. E., Karim, M. A., Falaguera, M. J., Speidel, L., Green, C., Logie, L., Schwartzentruber, J., Ochoa, D., Lord, J. M., Ferguson, M. A. J., et al. (2023) · Scientific Data · doi:10.1038/s41597-023-02513-4 · Cited by 8
Self-citationTargeting LC3/GABARAP for degrader development and autophagy modulationPreprint
Schwalm, M. P., Dopfer, J., Kumar, A. M., Greco, F., Bauer, N., Löhr, F., Heering, J., Cano, S., Lechner, S., Hanke, T., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.05.560930 · Cited by 7
Self-citationMerten, E. M., Sears, J. D., Leisner, T. M., Hardy, P. B., Ghoshal, A., Hossain, M. A., Asressu, K. H., Brown, P. J., Stashko, M. A., Herring, L. E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.22.586341 · Cited by 7
Self-citationChaetocin disrupts the SUV39H1–HP1 interaction independent of SUV39H1 methyltransferase activity
Han, L., Lee, J. B., Indermaur, E. W., & Keung, A. J. (2023) · Biochemical Journal · doi:10.1042/bcj20220528 · Cited by 6
Chemical coverage of human biological pathways
Kwak, H. A., Liu, L., Tredup, C., Röhm, S., Prinos, P., Böttcher, J., & Schapira, M. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104144 · Cited by 6
Self-citationToward target 2035: EUbOPEN - a public–private partnership to enable & unlock biology in the open
Tredup, C., Ackloo, S. Z., Beck, H., Brown, P. J., Bullock, A. N., Ciulli, A., Đikić, I., Edfeldt, K., Edwards, A. M., Elkins, J. M., et al. (2024) · RSC Medicinal Chemistry · doi:10.1039/d4md00735b · Cited by 6
Self-citationOn drug discovery against infectious diseases and academic medicinal chemistry contributions
Janin, Y. L. (2022) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.18.141 · Cited by 6
Improving data quality in chemical biology
Knapp, S., & Müller, S. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01449-5 · Cited by 6
Self-citationTeruya, K., Rankin, G. M., Chrysanthopoulos, P. K., Tonissen, K. F., & Poulsen, S. (2017) · ChemBioChem · doi:10.1002/cbic.201600598 · Cited by 6
Papagiannopoulos, C. I., Theodoroula, N. F., Kyritsis, K., Akrivou, M. G., Kosmidou, M. S., Tsouderou, K., Grigoriadis, N., & Vizirianakis, I. S. (2021) · Journal of Biological Research - Thessaloniki · doi:10.1186/s40709-020-00132-3 · Cited by 6
Cairns, A. G., McQuaker, S. J., Murphy, M. P., & Hartley, R. C. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1262-0_6 · Cited by 6
Epigenetic Modulators as Treatment Alternative to Diverse Types of Cancer
Gutiérrez, J. R., Salgado, A. R. M., De-Ávila-Arias, M., San-Juan-Vergara, H. G., Rosales, W., & Gomez, C. M. M. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867329666211228111036 · Cited by 6
Bioluminescent Zebrafish Transplantation Model for Drug Discovery
Hason, M., Jovicic, J., Vonkova, I., Bojic, M., Simon-Vermot, T., White, R. M., & Bartůněk, P. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.893655 · Cited by 6
Irazoqui, A. P., Menéndez, C. A., Steingruber, H. S., Gonzalez, A., Appignanesi, G. A., Buitrago, C., & Gerbino, D. C. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106222 · Cited by 6
Novel quinazolin-4(3H)-one based Cyclin K degraders regulate alternative polyadenylation activity
Sano, O., Ito, M., Saito, M., Toita, A., Tanaka, T., Maezaki, H., Araki, S., & Iwata, H. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.07.028 · Cited by 6
An Introduction to Chemogenomics
Chaikuad, A., & Merk, D. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3397-7_1 · Cited by 6
Pharmacological approaches to understanding protein kinase signaling networks
Stephenson, E. H., & Higgins, J. M. G. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1310135 · Cited by 6
Dong, J., Jassim, B. A., Milholland, K. L., Qu, Z., Bai, Y., Miao, Y., Miao, J., Ma, Y., Lin, J., Hall, M. C., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00149 · Cited by 6
Butler, K. V., Bohn, K. C., Hrycyna, C. A., & Jin, J. J. (2016) · MedChemComm · doi:10.1039/c6md00130k · Cited by 6
Self-citationProbing biological mechanisms with chemical tools
Kang, C., & Keller, T. H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104656 · Cited by 6
AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discovery
Potjewyd, F., Annor‐Gyamfi, J. K., Aubé, J., Chu, S., Conlon, I. L., Frankowski, K. J., Guduru, S. K. R., Hardy, B. P., Hopkins, M. D., Kinoshita, C., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12246 · Cited by 6
Self-citationEffectively utilizing publicly available databases for cancer target evaluation
Croft, D. R., Lodhia, P., Lourenco, S. D. S., & MacKay, C. (2023) · NAR Cancer · doi:10.1093/narcan/zcad035 · Cited by 7
Reproducibility in Biomedical Research
Mullane, K., Curtis, M. J., & Williams, M. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804725-5.00001-x · Cited by 8
A Medicinal Chemist’s Perspective on Transitioning from Industry to Academic Drug Discovery
Barrow, J. C. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00107 · Cited by 6
Docking, Scoring, and Virtual Screening in Drug Discovery
Spyrakis, F., Sarkar, A., & Kellogg, G. E. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc301 · Cited by 6
Design of an equilibrative nucleoside transporter subtype 1 inhibitor for pain relief
Wright, N. A., Matsuoka, Y., Park, H., He, W., Webster, C. G., Furutani, K., Fedor, J. G., McGinnis, A., Zhao, Y., Ouyang, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54914-7 · Cited by 5
NUAK kinases: Signaling mechanisms and therapeutic applications
Cullen, N. M., Rosston, P., Tufail, B., D'Armond, A. E., Patel, A. S., Khosravi, D. H., Collins‐Burow, B. M., Hoang, V. T., Martin, E. C., Drewry, D. H., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110565 · Cited by 5
Emerging opportunities and challenges in small molecule development for non-HSP90 chaperones
Tang, M., Wu, Q., Liu, Y., Liu, X., You, Q., & Wang, L. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118100 · Cited by 5
Pharmacologic interrogation of USP28 cellular function in p53 signaling
Bratt, A. S., Kilgas, S., Guzman, M. I. T., Magin, R. S., Maisonet, I. J., Starnbach, C. A., Teh, W. P., Varca, A. C., Hu, B., Guzman, E. T., et al. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.08.002 · Cited by 5
It's ok to be outnumbered – sub-stoichiometric modulation of homomeric protein complexes
Dimitrova, Y. N., Gutierrez, J. A., & Huard, K. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00212d · Cited by 6
Sharp, S. Y., Martella, M., D’Agostino, S., Milton, C. I., Ward, G., Woodhead, A., Richardson, C. J., Carr, M. G., Chiarparin, E., Cons, B. D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54356-1 · Cited by 6
Identifying and evaluating understudied protein kinases using biological and chemical criteria
Koch, S., & Bajorath, J. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00306g · Cited by 5
Beyond PAINs: Chemotype Sensitivity of Protein Methyltransferases in Screens
Gao, C., Margolis, B. J., Strelow, J. M., Vidler, L. R., & Mader, M. M. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00375 · Cited by 5
Self-citationAsquith, C. R. M., Temme, L., East, M. P., Laitinen, T., Pickett, J. E., Kwarcinski, F. E., Sinha, P., Wells, C. I., Johnson, G. L., Zutshi, R., et al. (2022) · ChemMedChem · doi:10.1002/cmdc.202200161 · Cited by 6
Shi, Y., & Carroll, K. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90219-9.00010-8 · Cited by 6
Pashenko, A. E., Gaidai, A. V., Hryhoriev, N., Volovenko, O. B., Levandovskiy, I. A., Maksymenko, O., Volochnyuk, D. M., & Ryabukhin, S. V. (2023) · Organic Process Research & Development · doi:10.1021/acs.oprd.2c00305 · Cited by 5
Tredup, C., Ndreshkjana, B., Schneider, N. S., Tjaden, A., Kemas, A. M., Youhanna, S. C., Lauschke, V. M., Berger, B., Krämer, A., Berger, L. M., et al. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.2c00877 · Cited by 5
Self-citationActivity-based probes in pathogenic bacteria: Investigating drug targets and molecule specificity
Lembke, H. K., & Carlson, E. E. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102359 · Cited by 5
Quantitative Prioritization of Tool Compounds for Phenotypic Screening
Wang, Y., & Jenkins, J. L. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7847-2_15 · Cited by 5
Opportunities for Lipid-Based Probes in the Field of Immunology
Koenders, S. T. A., Gagestein, B., & van der Stelt, M. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_127 · Cited by 5
Synthesis of Aza-acyclic Nucleoside Libraries of Purine, Pyrimidine, and 1,2,4-Triazole
Pathak, V., Pathak, A. K., & Reynolds, R. C. (2019) · ACS Combinatorial Science · doi:10.1021/acscombsci.8b00136 · Cited by 5
Neuromodulation by selective angiotensin-converting enzyme 2 inhibitors
Pozdnyakova, N., Krisanova, N. V., Pastukhov, A. O., Tarasenko, A. S., Dudarenko, M., Chernykh, A. V., Pashenko, A. E., Ryabukhin, S. V., Tolstanova, G. M., Volochnyuk, D. M., et al. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.07.003 · Cited by 5
Fluorescent Probe Combined with Photoelectric Analysis Technology for Detection of Escherichia coli
Cui, Q., Zhong, Y., Shang, W., Deng, F., Wang, B., Wu, J., Wang, P., Wan, L., Wang, K., Fang, L., et al. (2023) · Biosensors · doi:10.3390/bios13020150 · Cited by 5
Cellular analysis of the action of epigenetic drugs and probes
Hau, M., Zenk, F. L., Ganesan, A., Iovino, N., & Jung, M. (2017) · Epigenetics · doi:10.1080/15592294.2016.1274472 · Cited by 6
Jukič, M., Grabrijan, K., Kadić, S., de Lera-Garrido, F., Sosič, I., Gobec, S., & Obreza, A. (2017) · Acta chimica slovenica · doi:10.17344/acsi.2017.3883 · Cited by 5
Peptide Technologies in the Development of Chemical Tools for Chromatin‐Associated Machinery
Barnash, K. D., Lamb, K. N., James, L. I., & Frye, S. V. (2017) · Drug Development Research · doi:10.1002/ddr.21398 · Cited by 5
Self-citation
Metadata
- Authors
- Arrowsmith, C. H., Audia, J. E., Austin, C., Baell, J., Bennett, J., Blagg, J., Bountra, C., Brennan, P. E., Brown, P. J., Bunnage, M. E., Buser-Doepner, C., Campbell, R. M., Carter, A. J., Cohen, P., Copeland, R. A., Cravatt, B., Dahlin, J. L., Dhanak, D., Edwards, A. M., Frederiksen, M., Frye, S. V., Gray, N., Grimshaw, C. E., Hepworth, D., Howe, T., Huber, K. V. M., Jin, J., Knapp, S., Kotz, J. D., Kruger, R. G., Lowe, D., Mader, M. M., Marsden, B., Mueller-Fahrnow, A., Müller, S., O'Hagan, R. C., Overington, J. P., Owen, D. R., Rosenberg, S. H., Ross, R., Roth, B., Schapira, M., Schreiber, S. L., Shoichet, B., Sundström, M., Superti-Furga, G., Taunton, J., Toledo-Sherman, L., Walpole, C., Walters, M. A., Willson, T. M., Workman, P., Young, R. N., & Zuercher, W. J.
- Affiliations
- University of Toronto (CA)
- Constellation Pharmaceuticals (United States) (US)
- National Institutes of Health (US)
- Monash University (AU)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Institute of Cancer Research (GB)
- University of Oxford (GB)
- Structural Genomics Consortium (CA)
- Pfizer (United States) (US)
- Eli Lilly (United States) (US)
- Boehringer Ingelheim (Germany) (DE)
- University of Dundee (GB)
- Epizyme (United States) (US)
- Scripps Research Institute (US)
- Mayo Clinic (US)
- Novartis (Switzerland) (CH)
- University of North Carolina at Chapel Hill (US)
- Harvard University (US)
- Janssen (United Kingdom) (GB)
- Austrian Academy of Sciences (AT)
- Icahn School of Medicine at Mount Sinai (US)
- Broad Institute (US)
- GlaxoSmithKline (United States) (US)
- Vertex Pharmaceuticals (United States) (US)
- European Bioinformatics Institute (GB)
- AbbVie (United States) (US)
- University of California, San Francisco (US)
- Karolinska University Hospital (SE)
- Howard Hughes Medical Institute (US)
- University of Minnesota (US)
- Simon Fraser University (CA)
- Corresponding author
- Edwards, Aled M
- ORCID
- Arrowsmith, Cheryl H
- Audia, James E
- Austin, Christopher
- Baell, Jonathan
- Blagg, Julian
- Bountra, Chas
- Brennan, Paul E
- Brown, Peter J
- Bunnage, Mark E
- Campbell, Robert M
- Carter, Adrian J
- Cohen, Philip
- Copeland, Robert A
- Dahlin, Jayme L
- Edwards, Aled M
- Frederiksen, Mathias
- Frye, Stephen V
- Gray, Nathanael
- Grimshaw, Charles E
- Hepworth, David
- Huber, Kilian V M
- Jin, Jian
- Knapp, Stefan
- Kotz, Joanne D
- Mader, Mary M
- Marsden, Brian
- Müller, Susanne
- Overington, John P
- Owen, Dafydd R
- Ross, Ruth
- Roth, Bryan
- Schapira, Matthieu
- Schreiber, Stuart L
- Shoichet, Brian
- Sundström, Michael
- Taunton, Jack
- Walters, Michael A
- Willson, Timothy M
- Workman, Paul
- Young, Robert N
- Zuercher, William J
- Venue
- Nature Chemical Biology
- Published
- 2015-07-21
- Volume
- 11
- Issue
- 8
- Pages
- 536-541
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- PMC
- PMC4706458
- OpenAlex
- W1516646538
- Cited by
- 839
- References
- 41
- Citations by year
- 2026: 37 · 2025: 57 · 2024: 62 · 2023: 67 · 2022: 67 · 2021: 81 · 2020: 86 · 2019: 75 · 2018: 79 · 2017: 98 · 2016: 103 · 2015: 25
- FWCI
- 48.56
- Type
- journal article
- Language
- en
- Update notices
- erratum (2015-10-20)
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Chemical Biology (publishedVersion, other-oa)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion, other-oa)
- Deakin Research Online (Deakin University) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- UNC Libraries
- Funders
- Eli Lilly and Company
- Pfizer
- GlaxoSmithKline
- Harvard University
- University of Dundee
- Wellcome Trust (106169/Z/14/Z, 104104, 106169, 104104/A/14/Z, 100294)
- Constellation Pharmaceuticals
- Cancer Research UK (11566)
- University of Oxford
- Monash University
- Österreichischen Akademie der Wissenschaften
- University of Toronto
- National Institutes of Health
- University of North Carolina at Chapel Hill
- Novartis Institutes for BioMedical Research
- Medical Research Council (MR/K000985/1)
- National Institute of General Medical Sciences (R01GM103893)
- Janssen Research and Development
- National Center for Advancing Translational Sciences
- UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- chemical probes, best practices, wikis, research reproducibility, chemical biology
- MeSH terms
- Humans, Molecular Weight, Sensitivity and Specificity, Molecular Probes, Intellectual Property, Internet, Information Dissemination, Biomedical Research, Small Molecule Libraries
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review